PAVmed Inc. Common Stock

PAVMNASDAQUSD
5.06 USD
0.27 (4.98%)🟢PRE MARKET (AS OF 08:02 AM EDT)
🟢Market: OPEN

PAVmed Inc. Common Stock (PAVM) is currently trading at $5.06. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, PAVM trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Aug 26, 2026.

Open?$5.26
High?$5.26
Low?$5.06
Prev. Close?$5.32
Volume?852
Avg. Volume?36.2K
VWAP?$5.26
Rel. Volume?0.02x
Bid / Ask
Bid?$4.20 × 100
Ask?$6.45 × 100
Spread?$2.25
Midpoint?$5.33
Valuation & Ratios
Market Cap?42.5M
Shares Out?8.0M
Float?4.4M
Float %?60.3%
P/E Ratio?N/A
P/B Ratio?1.21
EPS?-$2.58
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
Employees
41
Market Cap
42.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2016-04-28
Address
360 MADISON AVENUE
NEW YORK, NY 10017
Phone: (212) 949-4319
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Neutral(0/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
0
Momentum?
77
Short Sent.?
85
Piotroski F-Score?4/9Mixed
Altman Z-Score?-9.89Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.52%Low
Short Interest?22.7K
Days to Cover?1.0
Free Float4.4M
Avg Daily Volume82.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?1.19Adequate
Quick Ratio?1.19Adequate
Cash Ratio?0.93Adequate
Debt/Equity?0.43Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
93
1.21CHEAP
P/S?
Peers
100
S&P
3
379.81HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.3CHEAP
EV/Sales?
Peers
100
S&P
3
480.84HIGH
Returns & Efficiency
ROE?
S&P
3
-58.9%WEAK
ROA?
S&P
3
-51.3%WEAK
Cash Flow & Enterprise
FCF?$-7782000
Enterprise Value?$53.9M
Fundamentals ratios updated end of day